Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

NCT05289167 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host Disease

Interventions

DRUG: Cyclophosphamide
DRUG: Abatacept
DRUG: Bortezomib

Sponsor

Northwell Health